AR111666A1 - TOPICAL COMPOSITIONS THAT HAVE THE OBJECT TO MAINTAIN AND RESTORE THE HOMEOSTASIS OF SKIN WATER - Google Patents

TOPICAL COMPOSITIONS THAT HAVE THE OBJECT TO MAINTAIN AND RESTORE THE HOMEOSTASIS OF SKIN WATER

Info

Publication number
AR111666A1
AR111666A1 ARP180101141A ARP180101141A AR111666A1 AR 111666 A1 AR111666 A1 AR 111666A1 AR P180101141 A ARP180101141 A AR P180101141A AR P180101141 A ARP180101141 A AR P180101141A AR 111666 A1 AR111666 A1 AR 111666A1
Authority
AR
Argentina
Prior art keywords
homeostasis
restore
maintain
topical compositions
skin water
Prior art date
Application number
ARP180101141A
Other languages
Spanish (es)
Original Assignee
Ricerfarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricerfarma Srl filed Critical Ricerfarma Srl
Publication of AR111666A1 publication Critical patent/AR111666A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones tópicas que comprenden N,O-carboximetilquitosano y sal de sodio o potasio de octasulfato de sacarosa como ingredientes activos.Topical compositions comprising N, O-carboxymethylchitosan and sodium or potassium salt of sucrose octasulfate as active ingredients.

ARP180101141A 2017-05-03 2018-05-02 TOPICAL COMPOSITIONS THAT HAVE THE OBJECT TO MAINTAIN AND RESTORE THE HOMEOSTASIS OF SKIN WATER AR111666A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000047632A IT201700047632A1 (en) 2017-05-03 2017-05-03 TOPIC COMPOSITIONS TO MAINTAIN AND RESTORE THE HYDRO-MOISTIC SKIN HOMEOSTASIS

Publications (1)

Publication Number Publication Date
AR111666A1 true AR111666A1 (en) 2019-08-07

Family

ID=59811930

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101141A AR111666A1 (en) 2017-05-03 2018-05-02 TOPICAL COMPOSITIONS THAT HAVE THE OBJECT TO MAINTAIN AND RESTORE THE HOMEOSTASIS OF SKIN WATER

Country Status (4)

Country Link
AR (1) AR111666A1 (en)
IT (1) IT201700047632A1 (en)
TW (1) TW201842917A (en)
WO (1) WO2018202456A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619995A (en) 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME
AU4941297A (en) * 1996-11-15 1998-06-10 Dumex-Alpharma A/S A method for promoting tissue repair
EP2737902A1 (en) * 2012-11-28 2014-06-04 Zarzatech, Inc. Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field

Also Published As

Publication number Publication date
WO2018202456A1 (en) 2018-11-08
TW201842917A (en) 2018-12-16
IT201700047632A1 (en) 2018-11-03

Similar Documents

Publication Publication Date Title
CL2020001762A1 (en) Crystalline forms of the 4-pyrimidinesulfamide derivative of procytentan. (divisional request 201902464)
BR122021018243A8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
ECSP16084431A (en) STABLE NON-COMPLEX IODINE COMPOSITIONS AND METHODS OF USE
CL2015002710A1 (en) Compositions of arni against component c5 of the complement and methods for its use.
MA39727A (en) Botanical antimicrobial compositions
PE20171178A1 (en) ORAL REHYDRATION COMPOSITION AND THE SAME METHODS
CL2020000220A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
CL2011002634A1 (en) Aqueous solution without ethyl alcohol comprising propanolol or a pharmaceutically acceptable salt thereof, an unsweetened sweetener and less than 0.01% (w / v) of a preservative; preparation procedure; use of the solution in the treatment of hemangiomas.
BR112019005329A2 (en) purified human milk oligosaccharide compositions
BR112017021527A2 (en) Calcium-based toothpastes to enhance absorption of active ingredients.
CO6660486A2 (en) Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that present with a deficit of the maturation of the cornea envelope
CL2018002897A1 (en) Formulation systems for antimicrobial glycolipids.
AR100456A1 (en) DENTYFRIC COMPOSITIONS THAT HAVE STABILITY OF ION FLUORIDE AND IMPROVED FLUORIDE RECOVERY
AR100452A1 (en) DENTAL COMPOSITIONS THAT HAVE OPTIMIZED PRESERVANTS
AR112292A1 (en) COSMETIC COMPLEX FOR BIOACTIVE HYDRATION, COSMETIC COMPOSITION, USE AND METHOD
CL2020000551A1 (en) Formulation for topical use for the control and prevention of parasites in animals.
AR111666A1 (en) TOPICAL COMPOSITIONS THAT HAVE THE OBJECT TO MAINTAIN AND RESTORE THE HOMEOSTASIS OF SKIN WATER
TR201909422T4 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol.
MX2019003764A (en) Aqueous composition derived from seawater and seaweed.
AR091705A1 (en) USE OF ZINC SULFATE COCET AS AN ANTIBACTERIAL AGENT AGAINST PROPIONIBACTERIUM ACNES
AR106659A1 (en) DENTYFRIC COMPOSITIONS WITH IMPROVED CONSUMER EXPERIENCE
EA201890911A1 (en) TRAZODON AND GABAPENTINE COMBINATION FOR PAIN TREATMENT
CL2020000221A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
CO2017002490A2 (en) Reductive cosmetic composition for topical application containing keratin and sulfur
CL2017003465A1 (en) Combined use of bumetanide with valproic acid or one of its pharmaceutically acceptable salts to restore cl-homeostasis and thereby allow the preparation of an effective drug in the treatment of epilepsy, and especially in the treatment of refractory epilepsy.

Legal Events

Date Code Title Description
FB Suspension of granting procedure